1. S.S.C

Board/University: Comilla

Year: 1983

Result: 1st Division

2. H.S.C

Institution: Dhaka College

Board/University: Dhaka

Year: 1985

Result: 1st Division

3. M.B.B.S

Institution: Chittagong Medical College

Board/University: Chittagong University

Year: 1992

Result: Regular pass

4. FCPS

Subject/Field: Medicine

Institution: Bangladesh College of Physicians and Surgeons

Year: 2000

Result: Pass

5. MD

Subject/Field: Hepatology

Institution: BSMMU/IPGMR

Board/University: Dhaka

Year: 2003

Result: Pass

1. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh

Authors: Shahinul Alam,Utpal Das Gupta, Mahbubul Alam, Jahangir Kabir, Ziaur Rahman Chowdhury, A. K. M. Khorshed Alam

Journal: Indian J Gastroenterology (2021) ; Vol: 33 ; pp: 452–457

2. Impact of metabolic risk factors on the severity and outcome of patients with alcohol?associated acute?on?chronic liver failure. Liver International.

Authors: Duseja A, De A, Taneja S, Choudhury AK, Devarbhavi H, Hu J, Hamid SS, Butt AS, Jafri SM, Ghazinian H,….Alam S,….. Chawla YK.

Journal: Liver International (2021) ; Vol: Jan ; 41 (1) ; pp: 150-7

3. Alam S, Abrar M, Islam S, Kamal M, Hasan MJ, Khan MA, Ahmad N.

Authors: Effect of telmisartan and vitamin E on liver histopathology with non?alcoholic steatohepatitis: A randomized, open?label, noninferiority trial.

Journal: JGH Open (2021) ; Vol: Aug;4(4): ; pp: 663-9

4. Combating the impact of COVID-19 on Public University Students through Subsidized Online Class: Evidence from Bangladesh.

Authors: B Begum F, Alam SZ, Alam S, Omar LN.

Journal: Indicators (2021) ; Vol: 11 ; pp: 27

5. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

Authors: Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, Zheng MH, Shiha G, Yilmaz Y, Gani R, Alam S

Journal: Hepatology international (2021) ; Vol: Oct 1 ; pp: 1-31

6. Non-alcoholic fatty liver disease (NAFLD) among underweight adults

Authors: Fahim SM, Chowdhury MA, Alam S

Journal: Clinical Nutrition ESPEN (2021) ; Vol: Aug 1 ; pp: 38:80-5

7. Eliminating Hepatitis B from Bangladesh by the Year 2030

Authors: Mustafa MG, Alam S, Azam MG, Alam MM, Islam MS, Khan M

Journal: Journal of Bangladesh College of Physicians and Surgeons (2021) ; Vol: May 12;38(3) ; pp: 145-9

8. Disease-specific out-of-pocket healthcare expenditure in urban Bangladesh

Authors: Rahman MM, Zhang C, Swe KT, Rahman MS, Islam MR, Kamrujjaman M, Sultana P, Hassan MZ, Alam S, Rahman MM

Journal: A Bayesian analysis. PloS one (2021) ; Vol: Jan 14;15(1) ; pp: e0227565

9. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).

Authors: Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, Hwang J, …..Alam S,…., Qi X, Cua IH, Suh JI, Park JG

Journal: Hepatology international (2021) ; Vol: Sep;14(5) ; pp: 690-700

10. Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without Insulin Resistance

Authors: Alam S, Anam K, Islam S, Mustafa G, Al Mamun A, Ahmad N

Journal: Journal of clinical and experimental hepatology (2021) ; Vol: Mar 1;9(2) ; pp: 176-81

11. . Effect of weight reduction on histological activity and fibrosis of lean nonalcoholic steatohepatitis patient

Authors: Alam S, Hasan MJ, Khan MA, Alam M, Hasan N

Journal: Journal of translational internal medicine (2021) ; Vol: Oct 12;7(3) ; pp: 106-14

12. Effect of weight reduction on histological activity and fibrosis of lean nonalcoholic steatohepatitis patient

Authors: Alam S, Hasan MJ, Khan MA, Alam M, Hasan N

Journal: Journal of translational internal medicine (2021) ; Vol: Oct 12;7(3) ; pp: 106-14.

13. Clinical Practice Guidance for Management of Anti HBc Positive Patients

Authors: Alam S, Islam S, Khan AH, Alam M, Azam G, Mustafa G, Hossain M, Khan M

Journal: Journal of Bangladesh College of Physicians and Surgeons (2021) ; Vol: Sep 30;37(4) ; pp: 196-201

14. A dynamic model to predict outcome in acute on chronic liver failure patients

Authors: Choudhury AK, Al Mahtab M, Rahman S, AlamS, Devarbhavi H, Duseja A, Taneja S, Sarin SK, Paulson I, Jain P, Kumar G. THU-040-AARC score

Journal: Journal of Hepatology (2021) ; Vol: Apr 1;70(1) ; pp: e177

15. Correlation of serum aspartate aminotransferase level to platelet count ratio index with non-alcoholic fatty liver disease activity score

Authors: Das DC, Alam S, Noor-E-Alam SM, Kamal M, Mollah FH

Journal: Bangabandhu Sheikh Mujib Medical University Journal (2021) ; Vol: Oct 3;12(3) ; pp: 142-5

16. Financing health care in B angladesh: P olicy responses and challenges towards achieving universal health coverage

Authors: Fahim SM, Bhuayan TA, Hassan MZ, AbidZafr AH, Begum F, Rahman MM, Alam S

Journal: The International journal of health planning and management (2021) ; Vol: Jan;34(1) ; pp: e11-20

17. Financing health care in Bangladesh: Policy responses and challenges towards achieving universal health coverage

Authors: Fahim SM, Bhuayan TA, Hassan MZ, AbidZafr AH, Begum F, Rahman MM, Alam S

Journal: The International journal of health planning and management (2021) ; Vol: Jan;34(1) ; pp: e11-20

18. Study on Association of Hypothyroidism in Patients with Nonalcoholic Fatty Liver Disease

Authors: Mustafa G, Naha PK, Alam S, Alam M, Mustafa R, Ahmad N

Journal: Surg. Gastroenterol (2021) ; Vol: 24(4) ; pp: 197-202

19. Correlation of Serum Adiponectin with Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

Authors: Mustafa G, Rashid HO, Alam S,Alam M, Mustafa R, et al

Journal: Academic Journal of Gastroenterology &Hepatology (AJGH) (2021) ; Vol: Jul; 1(2) ; pp: 000509

20. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Authors: Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, …………………Alam S, Devarbhavi H, Kim DJ

Journal: Hepatology international (2021) ; Vol: Jul;13(4) ; pp: 353-90

21. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

Authors: Sarin, S.K., Choudhury, A., Sharma, M.K., Maiwall, R., Al Mahtab, M., Rahman, S., Saigal, S., Saraf, N., Soin, A.S., Devarbhavi,……Alam S,… H. and Kim, D.J., 2019.

Journal: Hepatology international (2021) ; Vol: 13(4) ; pp: pp.353-390

22. Correlation of Albumin-Bilirubin (ALBI) Score with Child-Turcotte-Pugh (CTP) Score in the Evaluation of Liver Cirrhosis

Authors: Shafiq S, Khan MN, Majumder B, Alam S, Islam MS, Sultana T

Journal: American Journal of Laboratory Medicine (2021) ; Vol: Jul 2;4(3) ; pp: 60-4

23. Correlation of Albumin-Bilirubin (ALBI) Score with Child-Turcotte-Pugh (CTP) Score in the Evaluation of Liver Cirrhosis

Authors: Shafiq S, Khan MN, Majumder B, Alam S, Islam MS, Sultana T

Journal: American Journal of Laboratory Medicine (2021) ; Vol: Jul 2;4(3): ; pp: 60-4

24. Correlation of Albumin-Bilirubin (ALBI) Score with Child-Turcotte-Pugh (CTP) Score in the Evaluation of Liver Cirrhosis

Authors: Shafiq S, Khan MN, Majumder B, Alam S, Islam MS, Sultana T

Journal: American Journal of Laboratory Medicine (2021) ; Vol: Jul 2;4(3) ; pp: 60-4

25. Correlation of Foxp3 Gene Expression with Serum Alanine Transaminase (ALT) Levels and Hepatitis B Viral Load in Cirrhosis and Hepatocellular Carcinoma (HCC) Patients

Authors: Shahera U, Mujnhi US, Jahan M, Alam S, Nessa A, Tabassum S

Journal: Acta Scientific Nutritional Health (2021) ; Vol: 2(5): ; pp: 57-61

26. Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patient: a one year randomized control trial.

Authors: Alam S, Ghosh J, Mustafa G, Kamal M, Ahmad N.

Journal: Hepatic Medicine: Evidence and Research (2021) ; Vol: 10 ; pp: 23–31.

27. Past, present, and future of hepatitis B and fatty liver in Bangladesh.

Authors: Alam S, Azam G, Mustafa G, Alam M, Ahmad N.

Journal: GastroenterolHepatol Open Access (2021) ; Vol: 6(3) ; pp: 197.

28. Effect of pentoxifylline on histological activity and fibrosis of nonalcoholic steatohepatitis patients: A one year randomized control trial.

Authors: Alam S, Hasan SN, Mustafa G, Alam M, Kamal M, Ahmad N.

Journal: Journal of translational internal medicine (2021) ; Vol: Sep 30;5(3) ; pp: 155-63

29. Nonalcoholic Fatty Liver Disease: A New Frontier for Hepatology in Bangladesh and a Call for Action to Combat.

Authors: Alam S, Hossain MM, Azam G, Mustafa G, Alam M, Sayeed A, Khan M, Ahmad N.

Journal: Journal of Bangladesh College of Physicians and Surgeons (2021) ; Vol: 30;35(4) ; pp: 184-91

30. Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver

Authors: Alam S, Islam MS, Islam S, Mustafa G, Saleh AA, Ahmad N.

Journal: Indian Journal of Gastroenterology (2021) ; Vol: Sep;36(5) ; pp: 366-72

31. High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatitis C than Hepatitis B.

Authors: Azam G, Alam S, Khan AS, Giasuddin RS, Khan M.

Journal: International Journal of Life-Sciences Scientific Research. (2021) ; Vol: Sep;3(5) ; pp: 1365-9

32. Assessment of connective tissue growth factor and hyalunoric acid in the diagnosis of hepatic fibrosis in chronic Hepatitis B

Authors: Ferdoushi S, Islam MS, Mortaz R, Paul D, Begum MR, Sultana T et al

Journal: Dinajpur Med Col J (2021) ; Vol: 10 ; pp: 210-217

33. Assessment of connective tissue growth factor in the diagnosis of hepatic fibrosis in chronic hepatitis B: A correlation analysis.

Authors: Ferdoushi S, Mortaz RE, Bhuiyan MA, Begum R, Islam S, Paul D, et al.

Journal: Austin J ClinPathol (2021) ; Vol: 4(2) ; pp: 1050-1053

34. Food Safety Knowledge, Attitudes and Practices of Chotpoti Vendors in Dhaka, Bangladesh

Authors: Hassan MZ, Islam MS, Salauddin M, Zafr AH, Alam S. Food

Journal: Journal of Enam Medical College (2021) ; Vol: 69-76 ; pp: Jun 4;7(2)

35. Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial.

Authors: Alam S, Kabir J, Mustafa G, Gupta U, Hasan S, Alam A.

Journal: Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial (2021) ; Vol: Jan;22(1) ; pp: 69

36. Insulin resistance in development and progression of nonalcoholic fatty liver disease.

Authors: Alam S, Mustafa G, Alam M, Ahmad N.

Journal: World journal of gastrointestinal pathophysiology. (2021) ; Vol: May 15;7(2) ; pp: 211

37. Insulin resistance in nonalcoholic fatty liver disease: experience from Bangladesh

Authors: Azam G, Alam S, Hasan SN, Alam SM, Kabir J, Alam AK

Journal: Bangladesh Critical Care Journal (2021) ; Vol: Oct 21;4(2) ; pp: 86-91

38. Consumer subsequent plan for selection of hospital in the perspective of hospital services and expenditure.

Authors: Begum F, Alam S.

Journal: South East Asia Journal of Public Health. (2021) ; Vol: Dec 10;6(1) ; pp: 14-9

39. Healthcare financing in Bangladesh: Challenges and recommendations.

Authors: Hassan MZ, Fahim SM, Zafr AHA, Islam MS, Alam S

Journal: Bangladesh Journal of Medical Science (2021) ; Vol: 15 ; pp: 505-510

40. Detection of enteric bacteria in the popular street food chotpoti in Dhaka, Bangladesh.

Authors: Hassan MZ, Islam MS, Salauddin M, Zafor AH, Scott ML, Alam S.

Journal: Asian Journal of Medical and Biological Research (2021) ; Vol: 2(4) ; pp: 596-602

41. Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis.

Authors: Noor-E-Alam M, Alam S, Alam AK, Al Mahtab M, Rahman S.

Journal: Euroasian journal of hepato-gastroenterology (2021) ; Vol: Jul;6(2) ; pp: 202

42. Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis.

Authors: Noor-E-Alam M, Alam S, Alam AK, Al Mahtab M, Rahman S.

Journal: Euroasian journal of hepato-gastroenterology (2021) ; Vol: Jul;6(2): ; pp: 202

43. Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis.

Authors: Noor-E-Alam M, Alam S, Alam AK, Al Mahtab M, Rahman S.

Journal: Euroasian journal of hepato-gastroenterology (2021) ; Vol: Jul;6(2): ; pp: 202

44. IP-10, p53, and Foxp3 expression in hepatocytes of chronic hepatitis B patients with cirrhosis and hepatocellular carcinoma.

Authors: Shahera U, Munshi S, Jahan M, Nessa A, Alam S, Tabassum S.

Journal: Euroasian journal of hepato-gastroenterology (2021) ; Vol: Jul;6(2) ; pp: 149

45. Transaminases and gamma glutamyltranspeptidase for detecting nonalcoholic steatohepatitis and fibrosis in nonalcoholic fatty liver disease.

Authors: Alam S, Gupta UD, Kabir J, Noor-E-Alam SM, Chowdhury ZR, Alam AK.

Journal: Bangabandhu Sheikh Mujib Medical University Journal. (2021) ; Vol: 8(1): ; pp: 61-7

46. Ethical Relation between Physicians and Pharmaceutical Industries in the Perspectives of Bangladesh.

Authors: Alam S, Saman N, Hallaj MH, Alam JU, Majumder SM.

Journal: Bangladesh Journal of Bioethics (2021) ; Vol: Aug 1;6(1) ; pp: 1-5

47. Association of serum cytokeratin-18 fragment concentration in patients with different types of nonalcoholic fatty liver disease

Authors: Rahman T, Islam S, Ferdoushi S, Mortaz RE, Bhuiyan MMA, Sultana T, Alam S et al.

Journal: GastroenterolHepatol Open Access (2021) ; Vol: ; 2(2): ; pp: 00037- 41.

48. Variant of Ascitic Fluid Bacterial Infections in Patients of Liver Cirrhosis.

Authors: Sarker JA, Alam S, Khan M, Mahtab MA, Ashraf MS, Khondaker FA

Journal: Euroasian journal of hepato-gastroenterology. (2021) ; Vol: Jul;5(2): ; pp: 131.

49. Prevalence and predictor of nonalcoholic steatohepatitis (NASH) in nonalcoholic fatty liver disease (NAFLD).

Authors: Alam S, Alam M, Alam SM, Chowdhury ZR, Kabir J.

Journal: Journal of Bangladesh College of Physicians and Surgeons (2021) ; Vol: 32(2): ; pp: 71-7.

50. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh.

Authors: Alam S, Gupta UD, Alam M, Kabir J, Chowdhury ZR, Alam AK.

Journal: . Indian Journal of Gastroenterology (2021) ; Vol: Sep;33(5): ; pp: 452-7.

51. Funds for treatment of hospitalized patients: evidence from Bangladesh

Authors: Begum F, Alam S, Hossain A.

Journal: Journal of health, population, and nutrition (2021) ; Vol: Sep;32(3): ; pp: 465.

52. Prediction of oesophagealvarices in cirrhotic patients by measuring liver stiffness with fibroscan.

Authors: Alam S, Moben AL, Alam AK

Journal: Bangabandhu Sheikh Mujib Medical University Journal. (2021) ; Vol: 6(2): ; pp: 85-9.

53. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh.

Authors: Alam S, Noor-E-Alam SM, Chowdhury ZR, Alam M, Kabir J.

Journal: World Journal of Hepatology. (2021) ; Vol: May 27;5(5): ; pp: 281

54. Incidence of Bacteremia After Endoscopic Variceal Ligation of OesophagealVarices in Cirrhotic Patients.

Authors: Alam S, Lama TK, Alam AK.

Journal: Medicine Today. (2021) ; Vol: ;24(1): ; pp: 20-2.

55. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B

Authors: Alam S, Ahmad N, Mustafa G, Shrestha A, Alam AK, Khan M.

Journal: Liver international. (2021) ; Vol: Jul;31(6): ; pp: 824-30.

56. Per-cutaneous Liver Biopsy: Technique and Safety.

Authors: Mustafa G, Alam S, Al Mamun A, Ahmad N, Alam K, Khan M.

Journal: Hepatogastroenterology (2021) ; Vol: 58(106): ; pp: 529-31.

57. Hepatitis B virus related cirrhosis of liver decompensated by reactivation of cytomegalo virus infection- A case report.

Authors: Mustafa MG, Bhuyan AKMMR, Alam S,Mamun AA, Lama TK, Alam AKMK.

Journal: BSMMU J (2021) ; Vol: ; 4 (1): ; pp: 41-42.

58. Nonalcoholic fatty liver disease: The future frontier of Hepatology for South Asia. In: Baez RV Editor. Non-Alcoholic fatty liver disease - molecular basis, prevention and treatment.

Authors: 1.Alam S, Mustafa G, Alam M, Ahmad N.

Journal: London: Intechopen Limited; (2021) ; Vol: Published: March ; pp: 21st 2018

59. Changes of alanine aminotransferase and gamma glutamyltranspeptidase with histology of fatty liver.

Authors: Alam S, Mustafa G, Hasan SKM, Alam J, Ahmad N.

Journal: HepatolInt (2021) ; Vol: 2016;10(1): ; pp: 41A

60. Predictors of outcome of Acute B viral Hepatitis.

Authors: Alam S, Ahmad N, Mustafa G, Khan M.

Journal: Abstract Book of Single (2021) ; Vol: Topic Conference ; pp: APASL 20007.

61. Natural history of sepsis, organ failure and organ dysfunction in critically ill patients with acute on chronic liver failure.

Authors: • Misra M, Sarin SK …….Alam S….Yuen MF.

Journal: Journal of Hepatology (2019) ; Vol: 70(1): ; pp: e179-e180.

62. Effect of vitamin E and telmisartan on liver histopathology in nonalcoholic steatohepatitis: A randomized open labeled head to head study.

Authors: Alam S, Abrar M, Mustafa G, Kamal M, Ahmad N.

Journal: ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (2019) ; Vol: CONFERENCE BOOK ; pp:

63. Effect of vitamin E and telmisartan on liver histopathology in nonalcoholic steatohepatitis: A randomized open labeled head to head study.

Authors: Alam S, Abrar M, Mustafa G, Kamal M, Ahmad N.

Journal: ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (2018) ; Vol: CONFERENCE BOOK ; pp:

64. Correlation of IP-10 gene expression with Serum Alanine transaminase (ALT) levels and Hepatitis B viral load in cirrhosis and hepatocellular carcinoma (HCC) patients.

Authors: Shahera U, Jahan M, Nessa A, Alam S, Munshi S, Tabassum S.

Journal: HepatolInt (2018) (2018) ; Vol: 12 (Suppl 2): ; pp: S181–S661

65. Comparison between treatment outcome of Sitagliptin plus life style modification versus only life style modification in patients with biopsy proven nonalcoholic steatohepatitis.

Authors: Ghosh J, Alam S, Mustafa G.

Journal: HepatolInt (2018) (2018) ; Vol: 12 (Suppl 2): ; pp: S181–S661

66. Effect of weight reduction on histological activity and fibrosis of lean nonalcoholic steatohepatitis patient.

Authors: Alam S, Mustafa G, Islam S, Ahmad N.

Journal: HepatolInt (2018) ; Vol: (2018) 12 (Suppl 2): ; pp: S181–S661

67. Postoperative bile leakage: endoscopic management.

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA.

Journal: Proceeding of the 25th annual conference of Bangladesh Gastroenterology Society, (2018) ; Vol: February ; pp: 10-11, 2018. Dhaka, Bangladesh

68. Endoscopic Management of Bile Leakage after Cholecystectomy.

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA

Journal: Proceeding of the Conference of Bangladesh Society of Surgeons, 2017. (2017) ; Vol: December 7-10, ; pp: 2017. Dhaka, Bangladesh

69. Safety and Efficacy of ERCP in the management of Biliary Ascariasis.

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA .

Journal: Proceeding of the Conference of Society of Medicine, 2017. (2017) ; Vol: December 8-10, 2017. ; pp: Dhaka, Bangladesh

70. Reducing the cost of Endoscopic retrograde cholangiopancreatography (ERCP) reusing selective accessories in low income settings.

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA.

Journal: Proceeding of the 24th annual conference of Bangladesh Gastroenterology Society, 2017. (2017) ; Vol: 11-12February, 2017. ; pp: Dhaka, Bangladesh

71. Endoscopic management of Polyp in pediatric patients.

Authors: Sultana K, Hassan MZ, Masum GS, Zafr AHA,AlamS.

Journal: Proceeding of the annual conference of Bangladesh pediatric Gastroenterology Society, 2017. (2017) ; Vol: January ; pp: 27, 2017. Dhaka, Bangladesh

72. Endoscopic band ligation for active variceal hemorrhage.

Authors: Ali MA, Hassan MZ, Masum GS, Zafr AHA,Alam S.

Journal: Proceeding of the annual conference of LIVERCON, 2017. (2017) ; Vol: March ; pp: 4, 2017. Dhaka,

73. Propofol only total intravenous anesthesia (TIVA) during endoscopic retrograde cholangiopancreatography (ERCP): safety and efficacy.

Authors: Haider A, Hassan MZ, Masum GS, Zafr AHA,Alam S.

Journal: Proceeding of the annual conference of Bangladesh Society of Anesthesiology, 2017. (2017) ; Vol: March, ; pp: 2017. Dhaka, Bangladesh

74. Prevalence of fatty liver in Bangladesh: A nationwide population based study.

Authors: Alam S, Chowdhury MAB, Azam G, Ahsan M, Mustafa G, Hossain M, et al.

Journal: Hepatol Int. (2017) ; Vol: 2017 Feb;11(Suppl 1): ; pp: 1-1093.

75. Spectrum of liver disease in Bangladesh: Change over a decade.

Authors: Azam MG, Khan M, Saeed A, Uddin A, Sheikh R, Alam S.

Journal: Hepatology International 2017 (2017) ; Vol: Feb; 11(Suppl 1): ; pp: 1-1093.

76. Familial clustering of nonalcoholic fatty liver disease among the family members of nonalcoholic steatohepatitis cirrhotic patients.

Authors: Alam S, Islam S, Mustafa G, Ahmad N.

Journal: Journal of Clinical and Experimental Hepatology (2016) ; Vol: 2016; ; pp: Supl A.

77. Variant of ascitic fluid bacterial infections in patients of liver Cirrhosis

Authors: Sarker JA, Alam S, Ashraf SM, Alam SMNE, Khondaker MFA, Mahtab MA, Khan M.

Journal: HepatolInt 2016; (2016) ; Vol: 10(1): ; pp: 379 A.

78. IP-10, p53 and Foxp3 expression in hepatitis B patients with cirrhosis and hepatocellular carcinoma.

Authors: Shahera U, Tabassum S, Munshi SU, Jahan M, Alam S,Nessa A.

Journal: HepatolInt (2016) ; Vol: 2016;10(1): ; pp: 276 A.

79. Endoscopic management of hepatobiliary malignancy

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA.

Journal: Proceeding of the annual conference of Bangladesh Cancer Society, 2016. (2016) ; Vol: December, 2016. ; pp: Dhaka, Bangladesh

80. Non surgical management of cholidocholithiasis at a private health care facility in Dhaka, Bangladesh.

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA.

Journal: Proceeding of the 27th annual conference of APB, 2016. (2016) ; Vol: April ; pp: 27, 2016. Dhaka, Bangladesh

81. Success and safety of needle knife papillotomy in ERCP.

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA.

Journal: Proceeding of the 23rd annual conference of Bangladesh Gastroenterology Society, 2016 (2016) ; Vol: March, ; pp: 2016. Dhaka, Bangladesh

82. Ethical Relation between Physicians and Pharmaceutical Industries in the Perspectives of Bangladesh

Authors: Shahinul Alam, Nahiduzzaman, Monsur Hallaj, Jahangir Ul Alam, Shoaib Momen Majumder

Journal: Bangladesh Journal of Bioethics (2015) ; Vol: 6 ; pp: 1 - 5

83. Insulin resistance in nonalcoholic fatty liver disease revalidation of old concept in the new era.

Authors: Alam S, Das U, Hasan N, Kabir J, Das DC, Alam AKMK.

Journal: Hepatology International (2015) ; Vol: 2015;9: ; pp: S115

84. Effect of telmisartan on histological activity and fibrosis of non alcoholicsteatohepatitis patient a one year randomized control trial.

Authors: Alam S, Das U, Hasan N, Kabir J, Das DC, Alam AKMK.

Journal: Hepatology International (2015) ; Vol: 2015;9 : ; pp: S116

85. Comparison of effect of telmisartan and weight reduction on histological activity of nonalcoholic steatohepatitis: A one year randomised control trial.

Authors: Alam S, Das U, Hasan N, Kabir J, Das DC, Alam AKMK.

Journal: Journal of Clinical and Experimental Hepatology. (2015) ; Vol: 2015;5: ; pp: 2,S22

86. Endoscopic retrograde cholangiopancreatography (ERCP) minimizes needs of but not replaced surgery in cholidocholithiasis.

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA.

Journal: Proceeding of the Conference of Bangladesh Society of Surgeons, 2015. (2015) ; Vol: December, ; pp: 2015. Dhaka, Bangladesh

87. Difficult Endoscopic Retrograde Cholangiopancreatography (ERCP): a case series with video presentation.

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA.

Journal: Proceeding of the 22rd annual conference of Bangladesh Gastroenterology Society, 2015. (2015) ; Vol: March, ; pp: 2015. Dhaka, Bangladesh.

88. Non-surgical management of Polyp in pediatric patients.

Authors: Ali MA, HassanMZ, Masum GS, Zafr AHA,AlamS.

Journal: Proceeding of the annual conference of Bangladesh pediatric Gastroenterology Society, 2015. (2015) ; Vol: December 19, ; pp: 2015. Dhaka, Bangladesh

89. Comparison of effect of telmisartan and weight reduction on histological activity of nonalcoholic steatohepatitis: A one year randomised control trial.

Authors: Alam S,Kabir J, Mustafa G, Hasan SKMN, Alam AKMK.

Journal: Journal of Clinical and Experimental Hepatology (2015) ; Vol: 2015; ; pp: S

90. Bacteremia Following Endoscopic Ligation of OesophagealVarices in Cirrhotic Patients : Is it Common?

Authors: Alam S, Lama TKL, Khan M.

Journal: APASL Liver (2015) ; Vol: ; pp: Week Singapore

91. Funds for Treatment of Hospitalized Patients: Evidence from Bangladesh

Authors: Farhana Begum, Shahinul Alam, Akmal Hossain

Journal: J HEALTH POPUL NUTR (2014) ; Vol: 32 ; pp: 465-470

92. Prevalence and Predictor of Nonalcoholic Steatohepatitis (NASH) in Nonalcoholic Fatty Liver Disease (NAFLD).

Authors: Alam S, Alam M, Alam SMNE, Chowdhury ZR, Kabir J.

Journal: Banagladesh Coll Phys Surg (2014) ; Vol: 32 ; pp: 71-77

93. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh.

Authors: Alam S, Noor-E-Alam SM, Chowdhury ZR, Alam M, Kabir J

Journal: World J Hepatol. (2013) ; Vol: 5 ; pp: 281-7

94. Metabolic factors determining severity of nonalcoholic fatty liver disease.

Authors: Alam S, Kabir J, AlamSMNE.

Journal: APASL Liver Week Singapore (2013) ; Vol: Abstract Book ; pp: 2013.

95. Value of liver stiffness measurement with fibroscan for the prediction of oesophagealvarices in cirrhotic patients.

Authors: Alam S, Moben, S, Alam F, Majid A, Mahtab MA, Rahman, Ashraf S.

Journal: APASL Liver Week Singapore (2013) ; Vol: Abstract Book ; pp: 2013.

96. Clinical and biochemical predictive factors for nonalcoholic steatohepatitis (NASH) and advanced fibrosis in nonalcoholic fatty liver disease (NAFLD).

Authors: Chowdhury ZR, Alam S, Alam SMNE.

Journal: APASL Liver Week (2013) ; Vol: Singapore ; pp: Abstract Book 2013.

97. Efficacy and safety of prolonged 3-year lamivudine treatment in patient with chronic hepatitis B in Bangladesh.

Authors: Khan M, Azam MG, Alam S.

Journal: HepatolInt 2012; (2012) ; Vol: 6(1): ; pp: p 114 [Abstract]

98. Entecavir for chronic hepatitis B Bangladeshi patients: Interim analysis of 644 cases.

Authors: Khan M, Azam MG, Alam S.

Journal: HepatolInt 2012; (2012) ; Vol: 6(1): ; pp: p 115 [Abstract]

99. Per-cutaneous Liver Biopsy: Technique and Safety.

Authors: Mustafa G, Alam S, Al Mamun A, Ahmad N, Alam K, Khan M.

Journal: Hepatogastroenterology (2011) ; Vol: 58 ; pp: 529-31

100. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B

Authors: Alam S, Ahmad N, Mustafa G, Shrestha A, Alam AKM, Khan M.

Journal: Liv Int (2011) ; Vol: 31 ; pp: 824-830

101. Seroprevalence of Hepatitis B Virus in Parents and under 5 years Children in a Rural Area of Bangladesh.

Authors: Ahmad N, Alam S, Mustafa G, Chowdhury ZR, Baig RH, Ahmed M.

Journal: BSMMU J 2011 (2011) ; Vol: 4 (1): ; pp: 8.

102. Telbivudine for chronic hepatitis B Bangladeshi patients: Interim analysis of 365 cases.

Authors: Azam MG, Khan M, Alam S.

Journal: HepatolInt 2011; (2011) ; Vol: 5(1): ; pp: p 116 [Abstract]

103. Telbivudine versus lamivudine for chronic hepatitis B patients in Bangladesh: Results at 1 year.

Authors: Azam MG, Khan M, Alam S.

Journal: HepatolInt 2011; (2011) ; Vol: 5(1): ; pp: p 139 [Abstract]

104. Characteristics of chronic hepatitis B: Lower alanine transaminase level to start treatment in HBeAg negatives.

Authors: Alam S, Azam G, Mustafa G, Ahmad N, Khan M.

Journal: Gut (2011) ; Vol: 2011 60: ; pp: A59-A60.

105. Seroprevalence of hepatitis C virus in rural population of Bangladesh.

Authors: Khan M, Mustafa MG, Ahmad N, Alam MS, Baig RH, Chowdhry ZR, Ahmed M

Journal: Indian J Gastroenterol (2010) ; Vol: 29 ; pp: 38-39

106. Comparative study on presentation of biliary ascariasis with dead and living worms.

Authors: Alam S, Mustafa G, Rahman S, Kabir SA, Rashid HO, Khan M

Journal: Saudi J Gastroenterol (2010) ; Vol: 16 ; pp: 203-206

107. Management of chronic hepatitis with oral antiviral agents: Experience from Bangladesh.

Authors: Khan M, Azam MG, Alam S.

Journal: HepatolInt 2010; (2010) ; Vol: 4(suppl 1): ; pp: p S99 [Abstract]

108. Lamivudine for chronic hepatitis B virus infection: efficacy and drug resistance during long-term treatment.

Authors: Azam MG, Khan M, Alam S.

Journal: HepatolInt 2010; (2010) ; Vol: 4(1): ; pp: p 135 [Abstract]

109. Peginterferon alfa-2b (12 KD) in chronic hepatitis B patients in Bangladesh: A preliminary study.

Authors: Azam MG, Khan M, Alam S.

Journal: HepatolInt 2010; (2010) ; Vol: 4(1): ; pp: p 137 [Abstract]

110. Telbivudine in chronic hepatitis B: One-year result among Bangladeshi patients.

Authors: Azam MG, Khan M, Alam S.

Journal: HepatolInt 2010; (2010) ; Vol: 4(1): ; pp: p 141 [Abstract]

111. Natural course of fulminant hepatic failure: The scenario in Bangladesh and the differences from the West.

Authors: Shahinul Alam, Golam Azam, GolamMustafa, Khorshed Alam, Mobin Khan.

Journal: The Saudi Journal of Gastroenterology (2009) ; Vol: 15 ; pp: 229-233

112. Guidelines for the management of chronic hepatitis B in Bangladesh.

Authors: Alam K, Alam S, Mustafa G, Mamun AA, Ahmad N, Khan M.

Journal: Bangladesh J Hepatol (2009) ; Vol: 1(1): ; pp: 28-34.

113. Autoimmune hemolysis complicating acute viral hepatitis due to hepatitis A virus infection.

Authors: Alam S, Alam A, Shrestha A, Khan M.

Journal: Bangladesh J Hepatol (2009) ; Vol: 1 ; pp: 35-37.

114. Natural course of fulminant hepatic failure: The scenario in Bangladesh and the differences from the West.

Authors: Alam S,AzamG,Mustafa G, Alam K, Khan M.

Journal: The Saudi Journal of Gastroenterology (2009) ; Vol: 15(4): ; pp: 229-233.

115. Correlation of serum ammonia level in various grades of hepatic encephalopathic patients.

Authors: Mashud G, Khan M, AlamK,RahmanS,Ahmad N, Alam S.

Journal: Bangladesh J Hepatol 2009; (2009) ; Vol: 1(1): ; pp: 25-27.

116. Effects of lamivudine on histological changes of liver in chronic hepatitis B patients.

Authors: Zaki KMJ, Khan M, Alam K, Ahmad N, Kamal M, Alam S, et al.

Journal: Bangladesh J Hepatol (2009) ; Vol: 1(1): ; pp: 15-19.

117. Peginterferon alfa-2a in chronic hepatitis B patients in Bangladesh: A preliminary study.

Authors: Azam MG, Ahmad N, Alam S, Khan M.

Journal: HepatolInt 2009; (2009) ; Vol: 3(1): ; pp: p 127 [Abstract]

118. Role of HBV, HCV and aflatoxin in hepatocellular carcinoma in Bangladesh and comparison of PIVKA-II and AFP as diagnostic marker.

Authors: Chowdhury A, Karim MA, Alam S,Azam MG.

Journal: HepatolInt 2009; (2009) ; Vol: 3(1): ; pp: p 156 [Abstract]

119. Factors influencing development of viral resistance in lamivudine therapy for chronic hepatitis B.

Authors: Alam S, Azam MG, Khan M.

Journal: HepatolInt 2009; (2009) ; Vol: 3(1): ; pp: p 223 [Abstract]

120. Virologic and biochemical breakthrough in patients with chronic hepatitis B treated with lamivudine – a 3 years observation.

Authors: Azam MG, Ahmad N, Khan M, Alam S.

Journal: HepatolInt 2009; (2009) ; Vol: 3(1): ; pp: p 224 [Abstract]

121. Pretreatment and on-treatment predictors of viral breakthrough in lamivudine therapy for chronic hepatitis B

Authors: Shahinul Alam, Golam Azam, Mobin Khan et al.

Journal: Hepatology International (2008) ; Vol: 2 ; pp: 494-7

122. e-antigen-negative chronic hepatitis B in Bangladesh.

Authors: Ahmad N, Alam S, Mustafa G, Adnan AB, Baig RH, Khan M.

Journal: HepatobiliaryPancreat Dis Int. (2008) ; Vol: Aug 15;7(4): ; pp: 379-82.

123. Correlation between hepatitis B viral DNA load and extent of liver pathology in patients with chronic hepatitis B.

Authors: Alam S, Ahmad N, Alam K, Mustaf G, Khan M.

Journal: Hepatitis Monthly (2008) ; Vol: 8(3): ; pp: 185-189.

124. Characteristics of treatment naive chronic hepatitis B in Bangladesh: Younger populations are more affected; HBeAg-negatives are more advanced.

Authors: Alam S, Ahmad N, Mustafa G, Alam K, Khan M.

Journal: Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association. (2008) ; Vol: Jan;14(1): ; pp: 15.

125. Pretreatment and on-treatment predictors of viral breakthrough in lamivudine therapy for chronic hepatitis B.

Authors: Alam S, Azam G, Mustafa G, Ahmad N, Islam B, Podder PK, Khan M.

Journal: Hepatology international. (2008) ; Vol: Dec;2(4): ; pp: 494-7.

126. Antiviral resistance with lamivudine therapy in chronic hepatitis B.

Authors: Khan M, Alam S.

Journal: Orion Med J. (2008) ; Vol: 30: ; pp: 546.

127. Effect of Large Volume Paracentesis without Albumin on Renal Function in Cirrhotic Ascites.

Authors: Rashid HO, Alam S, Ahmad N, Alam K, Rahman S, Haque A, Mamun-Al-Mahtab, Khan M.

Journal: Hungarian Medical Journal. (2008) ; Vol: Mar 1;2(1): ; pp: 133-44.

128. Large volume paracentesis without albumin infusion causes no renal impairment in child’s grade C cirrhotic patients.

Authors: Rashid H-O, Alam S, Khan M.

Journal: J GatroenterolHepatol 2008; (2008) ; Vol: 23(suppl.51): ; pp: A74

129. Etiology and predictors of outcome of fulminant hepatic failure, Hepatitis E virus is the leading cause.

Authors: Alam S, Ahmad N, Mustafa G, Khan M.

Journal: Hepatology International 2008; (2008) ; Vol: ; pp: Supll

130. Biliary Ascariasis with dead worm is far more dangerous than with alive worm.

Authors: Alam S, Mustafa G, Rahman S, Rashid HO, Kabir S, Khan M.

Journal: Hepatology International 2008; (2008) ; Vol: ; pp: A

131. Not only Obesity but overweight is also is risk factor for Non alcoholic fatty liver disease.

Authors: Alam S, Ahmad N, Mustafa G, Khan M.

Journal: Hepatology International 2008; (2008) ; Vol: ; pp: A

132. Effect of acute viral hepatitis on NAFLD.

Authors: Rashid HO, SalimurRahman S, Alam S.

Journal: Hepatology International 2008; (2008) ; Vol: ; pp: A

133. Should Lamivudine be the first line drug in management of chronic hepatitis B.

Authors: Alam S, Mustafa G, Ahmad, Khan M.

Journal: Abstract book of APB (2008) ; Vol: Annual ; pp: Conference 2008.

134. Endoscopic Management of Choledocholithiasis.

Authors: Alam S, Mustafa G, Ahmad N, Khan M.

Journal: Abstract Book of (2008) ; Vol: APB Annual Conference ; pp: 2008.

135. Significance of hepatitis B viral DNA load on liver histology in chronic hepatitis B patients.

Authors: Alam S, Ahmad N, Mustafa G Khan M.

Journal: Abstract Book of (2008) ; Vol: Single Topic Conference of APASL ; pp: 2007.

136. Seroprevalence of hepatitis C virus infection among health care workers.

Authors: Alam S, Ahmad N, Khan M, Mustafa G.

Journal: Journal of Bangladesh College of Physicians and Surgeons (2007) ; Vol: 25(3): ; pp: 126-9.

137. Presentation and endoscopic management of biliary ascariasis.

Authors: Alam S, Mustafa G, Ahmad N, Khan M.

Journal: Southeast Asian journal of tropical medicine and public health (2007) ; Vol: 1;38(4): ; pp: 631.

138. Ultrasonography and computer tomography evaluation of hepatocellular carcinoma with cytohistopathological correlation.

Authors: Hoque HW, Alam S, Ahsan S, Islam MN.

Journal: Bangladesh Medical Research Council Bulletin (2007) ; Vol: 33(2): ; pp: 73-7.

139. Study on ascitic fluid complement 3 level in cirrhotic patients with spontaneous bacterial peritonitis and without spontaneous bacterial peritonitis

Authors: Mustafa G, Khan M, Alam K, Rahman S, Ahmad N, Alam S, Ahmed S.

Journal: Hepatogastroenterology (2007) ; Vol: Oct-Nov;54(79): ; pp: 1905-7.

140. Fatty liver; An overview

Authors: Rashid HO,Rahman S, Haque A, Mahtab MA, Alam S,Sarker K, Hossain MM, Hoque I.

Journal: Gastroenterology Today (2007) ; Vol: XI: ; pp: 106 -108.

141. Fatty liver: A risk factor for chronic liver disease and new strategy for its management

Authors: Rashid MH, Haque MA, Alam S,Sarker MK, Hossain MMI.

Journal: The Orion Medical Journal (2007) ; Vol: 26: ; pp: 427-4 5.

142. Palliative endoscopic stenting in biliary and pancreatic malignancy.

Authors: Alam S, Hassan MZ, Masum GS, Zafr AHA.

Journal: Proceeding of the 28th APB annual conference, 2017. (2007) ; Vol: March, 2017. ; pp: Dhaka, Bangladesh

143. Effect of large volume paracentesis without albumin on renal function in cirrhotic ascites.

Authors: Rashid HO, Alam S, Ahmad N, Alam K, Rahman S, Haque A, Khan M.

Journal: Hepatology International 2007; (2007) ; Vol: 1: ; pp: 3-242.

144. Patients profile of nonalcoholic fatty liver disease of Bangladesh.

Authors: Alam S, Mustafa G, Ahmad N, Khan M.

Journal: Hepatology International 2007; (2007) ; Vol: 1: ; pp: 3-242.

145. Study of complement 3 level in cirrhotic patients with spontaneous bacterial peritonitis.

Authors: Alam S, Mustafa G, Ahmad N, Khan M.

Journal: Hepatology International 2007; (2007) ; Vol: 1: ; pp: 3-242.

146. Endoscopic management of biliary ascariasis.

Authors: Alam S, Mustafa G, Ahmad N, Khan M.

Journal: Abstract Book, (2007) ; Vol: National Congress and Scientific Seminar of Bangladesh Society ; pp: of Medicine 2007.

147. Characteristics of E antigen negative chronic Hepatitis B.

Authors: Alam S, Mustafa G, Ahmad N, Khan M.

Journal: Abstract Book of (2007) ; Vol: National Congress and scientific Seminar of Bangladesh Society of Medicine ; pp: 2007.

148. Hepatobiliary and pancreatic ascariasis: presentation and endoscopic management.

Authors: Alam S, Khan M, Alam K, Rahman S, Ahmad N,Karim F.

Journal: Hepatology 2006; (2006) ; Vol: Journal of Gastroenterology and ; pp: 21: A58.

149. Fulminant hepatic failure: aetiology, clinical course and outcome; a report from developing country.

Authors: Khan M, Alam S,Alam K, Rahman S, Ahmad N, Karim F.

Journal: Journal of Gastroenterology and Hepatology 2006; (2006) ; Vol: 21: ; pp: A133.

150. Patient’s satisfaction in health care services.

Authors: Begum F, Alam S, Uddin S, Ullah L.

Journal: Medicine Today (2005) ; Vol: 17 (1): ; pp: 19-22.

151. Estimation of frusemide induced natriuresis for early detection of refractory ascites.

Authors: Alam S, Khan M, Ahmad M, Alam K, Rahman S.

Journal: Liver International 2005; (2005) ; Vol: abstract book: ; pp: abstract book: 267.

152. Patients Satisfaction: A comparative study between private and public sector at tertiary level hospital.

Authors: Begum F, Karmakar SS, Alam S, Ullah L

Journal: Medicine Today (2004) ; Vol: 16(1); ; pp: 8-13.

153. Measurement of radiation doses to personnel involved in management of Ca thyroid patients treated with 1311.

Authors: Begum F, Uddin G, Rashid H, Alam S.

Journal: Bangladesh Journal of Nuclear Medicine (2004) ; Vol: 7: ; pp: 62-67.

154. Okuda staging at presentation of hepatocellular carcinioma in Bangladesh.

Authors: Khan M, Alam S,Alam K, Rahman S, Ahmad N, Mamun AA.

Journal: Journal of Gastroenterology and Hepatology (2004) ; Vol: 2004;19: ; pp: A862.

155. Amoebic liver abscess- A prospective study.

Authors: Alam S, Patwary MSR,Rahman S, Rahman F, Bari MMA,RahmanS,et al.

Journal: Medicine Today (2003) ; Vol: 15: ; pp: 16-18.

156. Aetiology of pancytopenia- A clinical investigation.

Authors: Patwary MSR, Alam S, Rahman S, Latif MA.

Journal: Medic ine Today (2003) ; Vol: 15: ; pp: 3-6.

157. Seroprevalence and management of hepatitis B in Bangladesh

Authors: Khan M, Alam K, Rahman S, Alam S, Azam MG, Ahmed MK,et al.

Journal: Monduzzi Editor (2002) ; Vol: C926R ; pp: 9004.

158. Remote complications following gastric surgery-40 case study.

Authors: Patwary MSR, Alam S,Mahmood G, Begum, F.

Journal: Medicine Today (2002) ; Vol: 14: ; pp: 9-13.

159. Prognosis evaluation in acute anterior myocardial infarction by the ischemia grading on admission electrocardiogramme

Authors: Patwary MSR, Alam S.

Journal: Medicine Today (2002) ; Vol: 14: ; pp: 11-14.

160. Hospital presentation of Essential hypertension; A study of 200 cases in SBMCH, Barisal .

Authors: Alam S,Hossain MZ, Patwary MSR, Begum F, Azad AK.

Journal: Journal of Teachers Association (1999) ; Vol: xii: ; pp: 675-679.

161. Jaundice in pregnancy: Aetiopathology, presentation, management and prognosis.

Authors: Patwary MSR, Mahmood G, Alam S.

Journal: Bangladesh Medical Review (1998) ; Vol: xxiv: ; pp: 14-17.

1. Training Entry

Type: Foundation Training

Duration: Jan 01, 1970 - Jan 01, 1970

2. Training Entry

Type: Utilization Of Computer In Med

Duration: Jan 01, 1970 - Jan 01, 1970

3. Training Entry

Type: Training On Epidemiology, Bios

Duration: Jan 01, 1970 - Jan 01, 1970

4. Training Entry

Type: TOT Programme On Writing A Dis

Duration: Jan 01, 1970 - Jan 01, 1970

5. Training Entry

Type: Workshop on Scientific Writing

Duration: Jan 01, 1970 - Jan 01, 1970

6. Training Entry

Type: Workshop on Epidemiology of Li

Duration: Jan 01, 1970 - Jan 01, 1970